VentureBlick Joins SWITCH 2025 as Official Community Partner

Supporting Korean Startups’ Global Expansion through a Joint Pavilion with Hanyang University ERICA and the MEDITEK Organizing Committee

This article is a translation of the original article published by BioTimes. Read the original version here. 

Healthcare-focused global expansion partner VentureBlick (CEO: Chris Lee) participated in Singapore Week of Innovation & Technology (SWITCH 2025) as an official Community Partner, held in Singapore from October 29 to 31. The company contributed to expanding collaboration within the global innovation ecosystem through various initiatives.

During the event, VentureBlick played multiple roles—including operating a joint pavilion supporting Korean startups’ overseas expansion, co-hosting a special session with a leading global consumer healthcare company, and serving on the judging panel of an international pitching competition. Through these activities, the company further strengthened opportunities for Korean and Asian innovations to go global.

VentureBlick jointly organized the pavilion with the Gyeonggi Ansan Innopolis (Hanyang University ERICA Industry-University Cooperation Foundation) and the MEDITEK Organizing Committee. Four participating organizations—MEDITEK Organizing Committee, SOFNT, Advance Solution, and SGLabs—presented their innovative technologies and solutions while meeting potential global partners, investors, local institutions, and buyers to explore collaboration and overseas expansion opportunities.

On October 31, VentureBlick and Haleon, a global leader in consumer health, co-hosted a special session titled “Haleon @ SWITCH | Co-creating the Future of Consumer Health.” The program featured open innovation case studies, a panel discussion, and startup presentations. It provided local and international startups with networking opportunities to connect with global corporates and explore ways to apply and commercialize innovative technologies.

VentureBlick’s founder and CEO Chris Lee, who also served as a judge for the Health & Biomedical category of the SLINGSHOT 2025 pitching competition for the second consecutive year, said:

“As a SWITCH 2025 partner, VentureBlick served as a bridge connecting innovative technologies with the global healthcare ecosystem, turning collaboration into real business and investment opportunities. We’ll continue to support Korean innovators in growing globally and collaborating with partners worldwide.”

SWITCH is Asia’s largest global startup exhibition supporting networking among innovators, investors, and partners. Organized by Enterprise Singapore under the Ministry of Trade and Industry and supported by the National Research Foundation (NRF) under the Prime Minister’s Office, this year’s event—marking both Singapore’s 60th anniversary and SWITCH’s 10th edition—was held on its largest scale ever.

Headquartered in Singapore, VentureBlick operates subsidiaries in Korea, China, and India, supporting global expansion and scale-up for innovative healthcare companies worldwide. Backed by a network of over 6,500 clinicians and industry professionals across 60 countries, VentureBlick continues to connect innovators to new markets and partners.

In July, VentureBlick successfully hosted the “Korea-Singapore Healthcare Innovation Exchange Program,” strengthening mutual understanding between both countries’ healthcare innovation ecosystems and building a sustainable cooperation platform for continued collaboration.

Reporter: Kim Ji-Soo (news@biotimes.co.kr)